Nuhey News

We talk about the MARKET

Global Human Rabies Immunoglobulin (IM) Market Overview and Analysis of CSL Behring, Grifols, Sanofi and more

Human Rabies Immunoglobulin (HRIG) is a human-derived, sterile, and highly purified solution of human immunoglobulin used for the prevention and treatment of rabies. It is a preparation of antibodies, specifically immunoglobulins, that are used to provide protection against the rabies virus. HRIG is typically used as a prophylactic treatment after an animal bite or any other exposure to a potentially rabid animal. It is administered intramuscularly at the site of the bite or exposure, often along with a course of rabies vaccine.

HRIG is a safe and effective way to protect against rabies infection, and it is used in many countries around the world. The World Health Organization (WHO) recommends the use of HRIG for the prevention of rabies in post-exposure cases. The availability and cost of HRIG can vary by country, and some countries may not have access to HRIG at all. In the United States, HRIG is typically covered by health insurance, and the cost of HRIG is typically around $500-$1,000 per dose.

The global Human Rabies Immunoglobulin (IM) market was valued at US$ 396 million in 2022 and is anticipated to reach US$ 606.3 million by 2029, witnessing a CAGR of 6.2% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

A detailed market research report on Global Human Rabies Immunoglobulin (IM) Market available at:

This report aims to provide a comprehensive presentation of the global market for Human Rabies Immunoglobulin (IM), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Rabies Immunoglobulin (IM).

Global Human Rabies Immunoglobulin (IM) key players include CSL Behring, Grifols, Sanofi, etc. Global top three manufacturers hold a share about 60%.

Ask for more details or sample of this report at:

Release by:

Shirish Gupta

Marketing Manager

The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479